Skip to content

Clinical trials

Carcinoma, Renal Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Country / region: China Clear all

209 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20063
20072
20085
20091
20103
20114
20121
20135
20144
20153
20164
20174
20188
20196
20204
202116
202219
202327
202431
202530
202626

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting63
Unknown status52
Completed42
Active, not recruiting24
Not yet recruiting15
Terminated7
Suspended3
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
RenJi Hospital14
Sun Yat-sen University11
Peking Union Medical College Hospital10
Jinling Hospital, China9
Peking University First Hospital9
Tianjin Medical University Second Hospital8
Novartis Pharmaceuticals6
Peking University Cancer Hospital & Institute6
Chongqing Precision Biotech Co., Ltd5
Bayer4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell209
Kidney Neoplasms28
Carcinoma, Non-Small-Cell Lung16
Colorectal Neoplasms13
Melanoma12
Ovarian Neoplasms11
Neoplasm Metastasis10
Carcinoma, Hepatocellular9
Uterine Cervical Neoplasms9
Lung Neoplasms8

Trials

Showing 76 to 100 of 209. Each trial links to its page on Pharma Observatory.

109 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.